Italian registry for Head and Neck cancer patients
AIOCC Italian Registry on Head and Neck Carcinomas
This study is setting up a registry in Italy to collect important information about people with head and neck cancer to help improve research and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Italian Head&Neck Society Academic / other |
| Locations | 7 sites (Candiolo and 6 other locations) |
| Trial ID | NCT06248944 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a clinical registry in Italy to collect comprehensive data on patients diagnosed with Head and Neck carcinoma. It will gather information from multiple healthcare providers across selected investigational sites, allowing for both retrospective and prospective data collection. The data will be entered into an electronic case report form (eCRF) by healthcare professionals and analyzed using a privacy-preserving federated learning system called Vantage6. The registry will support observational studies and facilitate global collaborative research efforts.
Who should consider this trial
Good fit: Ideal candidates include adult patients aged 18 and older diagnosed with Head and Neck carcinoma, regardless of their current treatment phase.
Not a fit: Patients with sarcomas or lymphomas, or those whose medical records are unavailable for review, may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Head and Neck cancer treatment outcomes and improve patient care.
How similar studies have performed: Other observational registries have shown success in improving patient outcomes and facilitating research in similar cancer types.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients (age ≥ 18 years old) diagnosed with carcinoma of the Head and Neck. The diagnosis should be done or verified by the expert site entering the information about the patient in the registry. Patients diagnosed with sarcomas and lymphomas are excluded. 2. Patients entering the HCP at any clinical phase of the disease (diagnosis, treatment of primary cancer, treatment of recurrence, treatment of M+ etc.). The HCP will collect information on the entire disease regardless of when it started to manage the patient. The HCP can choose, based on its resources, for how many patients will be able to collect the data. 3. New patients managed by the HCP from 2021 onwards + patients managed by the HCP, in active follow-up at the hospital Exclusion Criteria: 1\. Patients whose medical records are unavailable for review
Where this trial is running
Candiolo and 6 other locations
- Fondazione del Piemonte per l'Oncologia - IRCCS — Candiolo, Italy (Recruiting)
- A.O.U. Careggi — Florence, Italy (Recruiting)
- P.O. 'Vito Fazzi' — Lecce, Italy (Recruiting)
- Fondazione IRCCS Istituto Nazionale Tumori — Milan, Italy (Recruiting)
- Fondazione CNAO — Pavia, Italy (Recruiting)
- Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS — Roma, Italy (Recruiting)
- Azienda Ospedaliera Universitaria Integrata di Verona — Verona, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.